Gene · 2826
Papers2,000
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,000
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| HTRA1 expression is associated with immune-cell infiltration and survival in breast cancer. | Transl Cancer Res | 2023 | 38197075 | PubTator, text mining | PubMed |
| ILC2-mediated immune crosstalk in chronic (vascular) inflammation. | Front Immunol | 2023 | 38179045 | PubTator, text mining | PubMed |
| Associations of the circulating levels of cytokines with risk of ankylosing spondylitis: a Mendelian randomization study. | Front Immunol | 2023 | 38173728 | PubTator, text mining | PubMed |
| CD24 May Serve as an Immunotherapy Target in Triple-Negative Breast Cancer by Regulating the Expression of PD-L1. | Breast Cancer (Dove Med Press) | 2023 | 38164371 | PubTator, text mining | PubMed |
| Transcriptomic correlates of cell cycle checkpoints with distinct prognosis, molecular characteristics, immunological regulation, and therapeutic response in colorectal adenocarcinoma. | Front Immunol | 2023 | 38143740 | PubTator, text mining | PubMed |
| Immune Profiling of Patients with Systemic Sclerosis through Targeted Proteomic Analysis. | Int J Mol Sci | 2023 | 38139427 | PubTator, text mining | PubMed |
| Systematic analysis based on the cuproptosis-related genes identifies ferredoxin 1 as an immune regulator and therapeutic target for glioblastoma. | BMC Cancer | 2023 | 38114959 | PubTator, text mining | PubMed |
| Early human lung immune cell development and its role in epithelial cell fate. | Sci Immunol | 2023 | 38100545 | PubTator, text mining | PubMed |
| Dynamic altruistic cooperation within breast tumors. | Mol Cancer | 2023 | 38093346 | PubTator, text mining | PubMed |
| Inflammatory cytokines as mediators of retinal endothelial barrier dysfunction in non-infectious uveitis. | Clin Transl Immunology | 2023 | 38090668 | PubTator, text mining | PubMed |
| Analysis of gene expression profile for identification of novel gene signatures during dengue infection. | Infect Med (Beijing) | 2023 | 38076406 | PubTator, text mining | PubMed |
| LAG3 is an independent prognostic biomarker and potential target for immune checkpoint inhibitors in malignant pleural mesothelioma: a retrospective study. | BMC Cancer | 2023 | 38062416 | PubTator, text mining | PubMed |
| TGFß1 Stimulates Lymphatic Endothelial Cells to Produce IL7 and IL15, Which Act as Chemotactic Factors for Breast Cancer Cells with Mesenchymal Properties. | J Mammary Gland Biol Neoplasia | 2023 | 38055067 | PubTator, text mining | PubMed |
| Young infants display heterogeneous serological responses and extensive but reversible transcriptional changes following initial immunizations. | Nat Commun | 2023 | 38042900 | PubTator, text mining | PubMed |
| Large-scale analysis of cell-cell communication reveals angiogenin-dependent tumor progression in clear cell renal cell carcinoma. | iScience | 2023 | 38025776 | PubTator, text mining | PubMed |
| Adoptive NK Cell Therapy - a Beacon of Hope in Multiple Myeloma Treatment. | Front Oncol | 2023 | 38023191 | PubTator, text mining | PubMed |
| Intestinal homeostasis in the gut-lung-kidney axis: a prospective therapeutic target in immune-related chronic kidney diseases. | Front Immunol | 2023 | 38022571 | PubTator, text mining | PubMed |
| Profound and selective lymphopaenia in primary lymphatic anomaly patients demonstrates the significance of lymphatic-lymphocyte interactions. | Front Immunol | 2023 | 38022535 | PubTator, text mining | PubMed |
| Organotypic heterogeneity in microvascular endothelial cell responses in sepsis-a molecular treasure trove and pharmacological Gordian knot. | Front Med (Lausanne) | 2023 | 38020105 | PubTator, text mining | PubMed |
| Identifying prognostic characteristics of m6A-related glycolysis gene and predicting the immune infiltration landscape in bladder cancer. | Cancer Cell Int | 2023 | 38017469 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2826/papers?page=5